Aptose Biosciences, Inc. (APTO) financial statements (2021 and earlier)

Company profile

Business Address 251 CONSUMERS ROAD
TORONTO, ON M2J 4R3
State of Incorp. ON
Fiscal Year End December 31
SIC 2836 - Biological Products, Except Diagnostic Substances (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in millions)

12/31/2020
12/31/2019
12/31/2018
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments1229816
Cash and cash equivalents1178015
Short-term investments5180
Prepaid expense311
Other current assets000
Total current assets:1259916
Noncurrent Assets
Operating lease, right-of-use asset11
Property, plant and equipment000
Total noncurrent assets:120
TOTAL ASSETS:12610017
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities653
Accounts payable221
Accrued liabilities431
Debt 1 
Other undisclosed current liabilities1  
Total current liabilities:763
Noncurrent Liabilities
Long-term debt and lease obligation11 
Operating lease, liability11
Other undisclosed noncurrent liabilities(1)  
Total noncurrent liabilities:11 
Total liabilities:773
Stockholders' equity
Stockholders' equity attributable to parent1199414
Common stock430365261
Additional paid in capital513533
Accumulated other comprehensive loss(4)(4)(4)
Accumulated deficit(357)(302)(276)
Total stockholders' equity:1199414
TOTAL LIABILITIES AND EQUITY:12610017

Income statement (P&L) ($ in millions)

12/31/2020
12/31/2019
12/31/2018
Operating expenses(56)(27)(29)
Operating loss:(56)(27)(29)
Nonoperating income110
Investment income, nonoperating110
Net loss available to common stockholders, diluted:(55)(26)(29)

Comprehensive Income ($ in millions)

12/31/2020
12/31/2019
12/31/2018
Net loss:(55)(26)(29)
Other comprehensive income (loss)(0)0 
Comprehensive loss, net of tax, attributable to parent:(55)(26)(29)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: